Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance

BACKGROUND: The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) as first-line treatment for uncomplicated malaria. Sudan revised its malaria treatment policy accordingly in 2004. However, eight years after ACTs were introduced in Sudan the patterns of ACT pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Pharmacol Toxicol
Egile Nagusiak: Elmannan, Abeer Abuzeid Atta, Elmardi, Khalid Abdelmutalab, Idris, Yassir Ali, Spector, Jonathan M, Ali, Nahid Abdelgadir, Malik, Elfatih Mohamed
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377183/
https://ncbi.nlm.nih.gov/pubmed/25889116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0002-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak